474 related articles for article (PubMed ID: 9447412)
21. Lens opacities in a rural population of southern India: the Aravind Comprehensive Eye Study.
Nirmalan PK; Krishnadas R; Ramakrishnan R; Thulasiraj RD; Katz J; Tielsch JM; Robin AL
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4639-43. PubMed ID: 14578379
[TBL] [Abstract][Full Text] [Related]
22. The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.
Glaser TS; Doss LE; Shih G; Nigam D; Sperduto RD; Ferris FL; Agrón E; Clemons TE; Chew EY;
Ophthalmology; 2015 Jul; 122(7):1471-9. PubMed ID: 25972257
[TBL] [Abstract][Full Text] [Related]
23. An independent evaluation of the Age-Related Eye Disease Study (AREDS) cataract grading system.
Braccio L; Camparini M; Graziosi P; Baratta G; Ferrigno L; Williams SL; Rosmini F; Sperduto RD; Maraini G
Curr Eye Res; 1998 Jan; 17(1):53-9. PubMed ID: 9472471
[TBL] [Abstract][Full Text] [Related]
24. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract.
Leske MC; Chylack LT; He Q; Wu SY; Schoenfeld E; Friend J; Wolfe J
Ophthalmology; 1998 May; 105(5):831-6. PubMed ID: 9593382
[TBL] [Abstract][Full Text] [Related]
25. A longitudinal study of body mass index and lens opacities. The Framingham Studies.
Hiller R; Podgor MJ; Sperduto RD; Nowroozi L; Wilson PW; D'Agostino RB; Colton T
Ophthalmology; 1998 Jul; 105(7):1244-50. PubMed ID: 9663229
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of lens opacities in Tehran: the Tehran Eye Study.
Hashemi H; Hatef E; Fotouhi A; Feizzadeh A; Mohammad K
Ophthalmic Epidemiol; 2009; 16(3):187-92. PubMed ID: 19437314
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3.
; Maraini G; Williams SL; Sperduto RD; Ferris F; Milton RC; Clemons TE; Rosmini F; Ferrigno L
Ophthalmology; 2008 Apr; 115(4):599-607.e1. PubMed ID: 18387406
[TBL] [Abstract][Full Text] [Related]
28. Senile cataract progression studies using the Lens Opacities Classification System II.
Magno BV; Datiles MB; Lasa SM
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2138-41. PubMed ID: 8491564
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for incident nuclear opacities.
Leske MC; Wu SY; Nemesure B; Hennis A;
Ophthalmology; 2002 Jul; 109(7):1303-8. PubMed ID: 12093655
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of lens opacities in North India: the INDEYE feasibility study.
Murthy GV; Gupta SK; Maraini G; Camparini M; Price GM; Dherani M; John N; Chakravarthy U; Fletcher AE
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):88-95. PubMed ID: 17197521
[TBL] [Abstract][Full Text] [Related]
31. LOCS III versus the Oxford Clinical Cataract Classification and Grading System for the assessment of nuclear, cortical and posterior subcapsular cataract.
Hall AB; Thompson JR; Deane JS; Rosenthal AR
Ophthalmic Epidemiol; 1997 Dec; 4(4):179-94. PubMed ID: 9500153
[TBL] [Abstract][Full Text] [Related]
32. Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.
Chang JR; Koo E; Agrón E; Hallak J; Clemons T; Azar D; Sperduto RD; Ferris FL; Chew EY;
Ophthalmology; 2011 Nov; 118(11):2113-9. PubMed ID: 21684602
[TBL] [Abstract][Full Text] [Related]
33. Postmenopausal hormone use and lens opacities.
Weintraub JM; Taylor A; Jacques P; Willett WC; Rosner B; Colditz GA; Chylack LT; Hankinson SE
Ophthalmic Epidemiol; 2002 Jul; 9(3):179-90. PubMed ID: 12045885
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors of lens opacities in the elderly in Finland. A population-based study.
Hirvelä H; Luukinen H; Laatikainen L
Ophthalmology; 1995 Jan; 102(1):108-17. PubMed ID: 7831024
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.
Chew EY; Kim J; Sperduto RD; Datiles MB; Coleman HR; Thompson DJ; Milton RC; Clayton JA; Hubbard LD; Danis RP; Ferris FL
Ophthalmology; 2010 Nov; 117(11):2112-9.e3. PubMed ID: 20561686
[TBL] [Abstract][Full Text] [Related]
36. Location and severity of cortical opacities in different regions of the lens in age-related cataract.
Graziosi P; Rosmini F; Bonacini M; Ferrigno L; Sperduto RD; Milton RC; Maraini G
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1698-703. PubMed ID: 8675414
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of cataract in Australia.
McCarty CA; Mukesh BN; Fu CL; Taylor HR
Am J Ophthalmol; 1999 Oct; 128(4):446-65. PubMed ID: 10577586
[TBL] [Abstract][Full Text] [Related]
38. Dietary carbohydrate intake and glycemic index in relation to cortical and nuclear lens opacities in the Age-Related Eye Disease Study.
Chiu CJ; Milton RC; Gensler G; Taylor A
Am J Clin Nutr; 2006 May; 83(5):1177-84. PubMed ID: 16685063
[TBL] [Abstract][Full Text] [Related]
39. Serum carotenoids and tocopherols and severity of nuclear and cortical opacities.
Mares-Perlman JA; Brady WE; Klein BE; Klein R; Palta M; Bowen P; Stacewicz-Sapuntzakis M
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):276-88. PubMed ID: 7843899
[TBL] [Abstract][Full Text] [Related]
40. Lens opacities classification system II (LOCS II).
Chylack LT; Leske MC; McCarthy D; Khu P; Kashiwagi T; Sperduto R
Arch Ophthalmol; 1989 Jul; 107(7):991-7. PubMed ID: 2751471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
